Visage Breast Density
K201411Visage Imaging GmbH · cleared 2021-01-29 · product code QIH · Radiology
Premarket evidence — what FDA accepted
source quote (p.3)
“Visage Breast Density is a software application intended for use with compatible full field digital mammography and digital breast tomosynthesis systems.”
source quote (p.5)
“Visage Breast Density employs a convolutional neural network (CNN) for the automatic classification of breast density. The CNN has been trained on a large database of mammography exams. When applied to a mammo-graphy image, the CNN computes four likelihoods corresponding to the four breast density categories. The classifications of the individual images are merged into a general classification of the mammography study.”
Validation studies (1)
Retrospective clinical
n=1,200 cases · 2 site(s)
endpoints: accuracies per category for ACR BI-RADS Atlas 5th Edition; total accuracy for ACR BI-RADS Atlas 5th Edition; accuracy for binary classification 'dense' versus 'non-dense'
Reported performance (1 observation)
source quote (p.6)
“The accuracies per category and the total accuracy were computed for the classification into the four categories of the ACR BI-RADS Atlas 5th Edition as well as for the binary classification 'dense' versus 'non-dense'.”
Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.
Predicate network
Postmarket — what happened after clearance
Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.
Reimbursement — how devices like this got paid
Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).